Back to Search
DR. DAVID HENRY URQUHART ANSLEY DO
DO
Internal Medicine Physician
NPI: 1952806697IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hospitalist Physician
Hospitalist
Code: 208M00000X
2021-01831(NC)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
DR.0073682(CO)
Education
PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE
Class of 2018
Research & Publications (18)
Rationale, design and baseline characteristics of the PRO-TECT II study: PROpofol CardioproTECTion for Type II diabetics: a randomized, controlled trial of high-dose propofol versus isoflurane preconditioning in patients undergoing on-pump coronary artery bypass graft surgery.
PMID 19336262·Contemp Clin Trials·2009
4-observational
The relationship between plasma free 15-F2t-isoprostane concentration and early postoperative cardiac depression following warm heart surgery.
PMID 14566285·J Thorac Cardiovasc Surg·2003
8-other
Target-achieved propofol concentration during on-pump cardiac surgery: a pilot dose-finding study.
PMID 19639375·Can J Anaesth·2009
2-rct
Quantitative analysis of propofol in whole blood using capillary electrophoresis.
PMID 19223250·J Chromatogr B Analyt Technol Biomed Life Sci·2009
8-other
Propofol reduces apoptosis and up-regulates endothelial nitric oxide synthase protein expression in hydrogen peroxide-stimulated human umbilical vein endothelial cells.
PMID 17898383·Anesth Analg·2007
8-other
Large-dose propofol during cardiopulmonary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: a comparison with isoflurane.
PMID 16931656·Anesth Analg·2006
4-observational
Propofol dose-dependently reduces tumor necrosis factor-alpha-Induced human umbilical vein endothelial cell apoptosis: effects on Bcl-2 and Bax expression and nitric oxide generation.
PMID 15920191·Anesth Analg·2005
8-other
Endothelin A and B receptor antagonist bosentan reduces postischemic myocardial injury in the rat: critical timing of administration.
PMID 15870840·Can J Physiol Pharmacol·2005
7-preclinical
15-F(2t)-isoprostane exacerbates myocardial ischemia-reperfusion injury of isolated rat hearts.
PMID 15937102·Am J Physiol Heart Circ Physiol·2005
7-preclinical
[Clinical significance of plasma free 15-F2t-isoprostane concentration during coronary artery bypasses graft surgery].
PMID 15009967·Zhongguo Wei Zhong Bing Ji Jiu Yi Xue·2004
4-observational
Application of high-dose propofol during ischemia improves postischemic function of rat hearts: effects on tissue antioxidant capacity.
PMID 15573153·Can J Physiol Pharmacol·2004
4-observational
Anesthetic preconditioning versus anesthetic treatment: effects on ischemic injury in isolated hearts.
PMID 15114246·Anesthesiology·2004
7-preclinical
Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: effects on 15-F2t-isoprostane formation.
PMID 12665253·Can J Physiol Pharmacol·2003
7-preclinical
Propofol enhances ischemic tolerance of middle-aged rat hearts: effects on 15-F(2t)-isoprostane formation and tissue antioxidant capacity.
PMID 12829182·Cardiovasc Res·2003
4-observational
Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease.
PMID 14666012·J Thorac Cardiovasc Surg·2003
3-trial
Propofol preservation of myocardial function in patients undergoing coronary surgery using cardiopulmonary bypass is dose dependent.
PMID 12657874·Anesthesiology·2003
8-other
Tissue antioxidant capacity during anesthesia: propofol enhances in vivo red cell and tissue antioxidant capacity in a rat model.
PMID 11772807·Anesth Analg·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via POUDRE VALLEY MEDICAL GROUP, LLC · 3 locations total
- Address
- 1400 E BOULDER ST STE 2508
COLORADO SPRINGS, CO 80909 - Phone
- (719) 365-1292
Quick Facts
- NPI
- 1952806697
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 3
- Years in Practice
- 8
- Publications
- 18
Are you this provider?
Claim Your Profile